Sometimes a beaten-down stock can present a valuable opportunity.While some stocks may trade at cheap valuations for very valid reasons, there's always more than share prices to consider when you're considering a business to add to your portfolio. When you invest in stocks for many years at a time, the list of companies you're willing to put capital into and hold for that long may narrow.Great companies don't suddenly become less so because the tide of investor sentiment shifts. Sometimes, quality businesse ...

文章核心观点 - CVS Health Corporation(CVS)被指控在2023年5月3日至2024年4月30日期间做出虚假和/或误导性陈述,并未披露以下信息[1][3][4]: 1) CVS用于确定计划保费的预测无法有效地考虑医疗成本趋势和医疗服务利用模式 2) 因此,CVS可能会产生大量费用来弥补未在预测中考虑的成本增加,这些成本并未包括在计划保费中 3) 因此,CVS夸大了其医疗保健福利分部的盈利能力 4) 与高管的保证相反,CVS其他主要分部的收入不足以抵消医疗保健福利分部支出增加的负面财务影响 根据相关目录分别进行总结 财务表现 - 2023年8月2日,CVS将其稀释每股收益(EPS)指引范围从6.90美元至7.12美元下调至6.53美元至6.75美元,并表示营业收入较上年同期下降30.7%,主要是由于医疗保健福利分部的下降[5] - 2024年2月7日,CVS将其稀释EPS指引范围从至少7.26美元下调至至少7.06美元,将其经调整EPS指引范围从至少8.50美元下调至至少8.30美元,将其营业活动产生的现金流指引从至少125亿美元下调至至少120亿美元[6] - 2024年5月1日,CVS报告收入884亿美元,低于预期的890亿美元,表示医疗服务利用率上升,即保险支出增加,以及Medicare报销率下降,将继续对CVS的业绩产生压力[7] 公司概况 - CVS是一家医疗保健公司[3] - Robbins Geller Rudman & Dowd LLP是一家全球领先的复杂集体诉讼公司,代表原告提起证券欺诈案件[8]

SAN DIEGO, July 27, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of CVS Health Corporation (NYSE: CVS) securities between May 3, 2023 and April 30, 2024, both dates inclusive (the “Class Period”), have until September 10, 2024 to seek appointment as lead plaintiff of the CVS class action lawsuit. Captioned Nixon v. CVS Health Corporation, No. 24-cv-05303 (S.D.N.Y.), the CVS class action lawsuit charges CVS as well as certain of CVS’s top cu ...

Investors can contact the law firm at no cost to learn more about recovering their losses. LOS ANGELES, July 26, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises CVS Health Corporation ("CVS" or the "Company") (NYSE: CVS) investors who suffered substantial losses to contact Lesley Portnoy, Esq. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Po ...

NEW YORK, July 25, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of CVS Health Corporation (NYSE: CVS) between May 3, 2023 and April 30, 2024. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by September 10, 2024.For more information, and to join the CVS Health Corporation class action, go to https://rosenlegal.com/submit-form/?ca ...

SAN DIEGO, July 23, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired CVS Health Corporation (NYSE: CVS) securities between May 3, 2023 and April 30, 2024. CVS is a healthcare company. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that CVS Health Corporation (CVS) Misled I ...

CVS Caremark pledges to accelerate transparency, drive to lowest net cost prescription drugs, strengthen pharmacy relations, and deliver the best clinical care in pharmacy WOONSOCKET, R.I., July 23, 2024 /PRNewswire/ -- CVS Caremark®, the nation's leading pharmacy benefit manager and a CVS Health® (NYSE: CVS) company, today announced a renewed pledge to American businesses, unions, and health plans — building on what the company is doing to deliver greater transparency, lower drug costs, and better clinical ...

NEW YORK, July 22, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of CVS Health Corporation (NYSE: CVS). Shareholders who purchased shares of CVS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/cvs-health-corporation-loss-submission-form-2/?id=91404&from=3 CLASS PERIOD: Ma ...

NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of CVS Health Corporation (NYSE: CVS) between May 3, 2023 and April 30, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 10, 2024. SO WHAT: If you purchased CVS Securities during the Class Pe ...

NEW YORK, July 18, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation ("CVS" or the "Company") (NYSE: CVS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 24-cv-05303, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired CVS securities between May 3, 2023 and April 30, 2024, both da ...